From a GMP standpoint- does anyone have any experiences (specifically with the FDA) running a method that requires collection at two wavelengths? If I use dual wavelength collection-how would I go about treating my unknowns? Would I be obligated to integrate everything in both wavelengths? How does this affect the investigation limits?